Preliminary results suggest that patients with aggressive non-Hodgkin’s lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.

(more…)

Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer. The B-cell receptor on the surface of B cells can cooperate with the MYC oncogene to accelerate the development of lymphomas. The research team, led by Yosef Refaeli, PhD, Assistant Professor of Pediatrics at National Jewish Medical and Research Center , also showed that disruption of signals from the B-cell receptor can inhibit growth of the tumors. The research is being published in the June 24 issue of the journal, PLos Biology.

(more…)

Vitamin C’s low toxicity lends high hopes to pioneering study

Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.

(more…)

Filed under: Non-Hodgkins Lymphoma, Hodgkin’s Lymphoma, Products

(more…)

Filed under: Non-Hodgkins Lymphoma, Liver Cancer, Daily news

(more…)

Filed under: Non-Hodgkins Lymphoma, Prevention, Diets, Daily news

(more…)

Filed under: Hodgkin’s Lymphoma, Cancer by the Numbers

(more…)

Filed under: Non-Hodgkins Lymphoma

(more…)

Filed under: Drug, Chemotherapy, Non-Hodgkins Lymphoma, Clinical Trials, Research

(more…)

Filed under: Chemotherapy, Non-Hodgkins Lymphoma, Daily news, Sports

(more…)